Harvard Bioscience Inc. (HBIO)
Harvard Bioscience Max Pain By Strike
HBIO trades at $0.49, 2.0% below the near-term max pain of $0.5 expiring Sep 19, 2025 (26 days). Price stability likely with balanced options positioning at this level. Max pain is stable across expirations ($0.5-$0.5), indicating stable market expectations. Key magnetic zone at 1 where 4 expirations converge.
Harvard Bioscience Max Pain By Expiry
Max pain for HBIO shows stable levels around 0.50, reflecting balanced market expectations. The 0% spread suggests strong consensus on fair value. Most levels above 0.49 could support dips. Strong magnetic level at 1 (4 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Sep 19, 2025 | 0.5 | 0.01 (1.56%) |
| Oct 17, 2025 | 0.5 | 0.01 (1.56%) |
| Nov 21, 2025 | 0.5 | 0.01 (1.56%) |
| Feb 20, 2026 | 0.5 | 0.01 (1.56%) |